WO2005115336A3 - Sprayable formulations for the treatment of acute inflammatory skin conditions - Google Patents

Sprayable formulations for the treatment of acute inflammatory skin conditions Download PDF

Info

Publication number
WO2005115336A3
WO2005115336A3 PCT/US2005/016812 US2005016812W WO2005115336A3 WO 2005115336 A3 WO2005115336 A3 WO 2005115336A3 US 2005016812 W US2005016812 W US 2005016812W WO 2005115336 A3 WO2005115336 A3 WO 2005115336A3
Authority
WO
WIPO (PCT)
Prior art keywords
foam
formulation
spray
treatment
drug
Prior art date
Application number
PCT/US2005/016812
Other languages
French (fr)
Other versions
WO2005115336A2 (en
Inventor
Mark Hirsh
Jane Hirsh
Mark Trumbore
Ira Skolnik
Original Assignee
Collegium Pharmaceutical Inc
Mark Hirsh
Jane Hirsh
Mark Trumbore
Ira Skolnik
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Collegium Pharmaceutical Inc, Mark Hirsh, Jane Hirsh, Mark Trumbore, Ira Skolnik filed Critical Collegium Pharmaceutical Inc
Publication of WO2005115336A2 publication Critical patent/WO2005115336A2/en
Publication of WO2005115336A3 publication Critical patent/WO2005115336A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams

Abstract

A topical spray or foam, methods of making the formulation, and methods of use thereof, has been developed. In one preferred embodiment, the composition includes one or more active agents and exhibits both antibacterial activity and antifungal activity. Excipients such as chemical disinfectants, antipruritic agents to minimize itching, and skin protective compounds may be added. The composition may be formulated to be dispensed as a spray or foam and the spray or foam may be administered either by a hand pump or by an aerosolizing propellant. A second single phase formulation has also been developed. The formulation comprises a first drug which is water soluble or hydrophilic and a second drug which is lipid soluble or hydrophobic, wherein at least one of the drugs is bound to an ion-exchange resin. The use of binding resins, such as ion-exchange resins, allows drugs with incompatible solvent requirements to be prepared in a single-phase formulation.
PCT/US2005/016812 2004-05-15 2005-05-13 Sprayable formulations for the treatment of acute inflammatory skin conditions WO2005115336A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US57117804P 2004-05-15 2004-05-15
US60/571,178 2004-05-15
US65530605P 2005-02-23 2005-02-23
US60/655,306 2005-02-23

Publications (2)

Publication Number Publication Date
WO2005115336A2 WO2005115336A2 (en) 2005-12-08
WO2005115336A3 true WO2005115336A3 (en) 2006-05-04

Family

ID=34969599

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/016812 WO2005115336A2 (en) 2004-05-15 2005-05-13 Sprayable formulations for the treatment of acute inflammatory skin conditions

Country Status (2)

Country Link
US (1) US20050255048A1 (en)
WO (1) WO2005115336A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9359471B2 (en) 2014-04-21 2016-06-07 Gaco Western, LLC Foam compositions

Families Citing this family (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
EP1556009B2 (en) 2002-10-25 2021-07-21 Foamix Pharmaceuticals Ltd. Cosmetic and pharmaceutical foam
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US8119109B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US8119150B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
RU2351315C2 (en) * 2003-07-24 2009-04-10 Смитклайн Бичам Корпорейшн Films, dissolving in mouth cavity
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
WO2005032521A2 (en) * 2003-10-02 2005-04-14 Collegium Pharmaceutical, Inc. Non-flammable topical anesthetic liquid aerosols
US20060188449A1 (en) * 2003-10-03 2006-08-24 Jane Hirsh Topical aerosol foams
US20070069046A1 (en) * 2005-04-19 2007-03-29 Foamix Ltd. Apparatus and method for releasing a measure of content from a plurality of containers
CA2610662A1 (en) 2005-05-09 2007-05-18 Foamix Ltd. Foamable vehicle and pharmaceutical compositions thereof
FR2890559B1 (en) * 2005-09-13 2011-06-24 Galderma Sa DERMATOLOGICAL FOAMS BASED ON METRONIDAZOLE AND EMULSIONS FOR PREPARATION
FR2890560B1 (en) * 2005-09-13 2011-06-24 Galderma Sa METRONIDAZOLE DERMATOLOGICAL FOAMS AND EMULSIONS FOR THEIR PREPARATION
WO2007050543A2 (en) * 2005-10-24 2007-05-03 Collegium Pharmaceutical, Inc. Topical pharmaceutical foam composition
EP2206494B1 (en) 2006-03-31 2015-12-02 Stiefel Research Australia Pty Ltd Foamable suspension gel
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
FR2913597B1 (en) * 2007-03-14 2009-10-09 Chanel Parfums Beaute Soc Par COSMETIC USE OF ORGANIC RESINATES
FR2915097B1 (en) * 2007-04-18 2012-09-28 Fabre Pierre Dermo Cosmetique ANTIFUNGAL FOAM BASED ON CICLOPIROXOLAMINE AND ZINC PYRITHIONE AND ITS MEDICAL AND COSMETIC APPLICATIONS.
BRPI0809869A2 (en) 2007-05-01 2014-09-30 Oplon Bv MEDICAL DEVICES, IMPLANTS AND CURATIVES FOR BIOCIDED WOUNDS
US20080287373A1 (en) * 2007-05-17 2008-11-20 Popp Karl F Topical skin treating kits
EP1994938A1 (en) * 2007-05-21 2008-11-26 Combinature Biopharm AG New lipoglycodepsipeptide compositions
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
WO2009056991A2 (en) * 2007-09-04 2009-05-07 Foamix Ltd. Device for delivery of a foamable composition
WO2009032907A2 (en) * 2007-09-04 2009-03-12 Quinnova Pharmaceuticals, Inc. Stay-on selenium foam
TWI428091B (en) * 2007-10-23 2014-03-01 Du Pont Fungicidal mixtures
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
WO2010041141A2 (en) 2008-10-07 2010-04-15 Foamix Ltd. Oil-based foamable carriers and formulations
WO2009072007A2 (en) 2007-12-07 2009-06-11 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
CA2712120A1 (en) 2008-01-14 2009-07-23 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
US8652443B2 (en) * 2008-02-14 2014-02-18 Precision Dermatology, Inc. Foamable microemulsion compositions for topical administration
WO2010093382A1 (en) 2009-02-12 2010-08-19 Collegium Pharmaceutical, Inc. Foamable benzoyl peroxide compositions for topical administration
FR2943914A1 (en) * 2009-04-06 2010-10-08 Fabre Pierre Dermo Cosmetique MOISTURE BOTTLE COMPRISING A PHARMACEUTICAL COMPOSITION
CA2760186C (en) 2009-04-28 2019-10-29 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
WO2011013008A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011013009A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
JP2013503820A (en) * 2009-09-01 2013-02-04 イーエルシー マネージメント エルエルシー Cosmetic composition comprising an ion exchange polymer and method of use thereof
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
US8871184B2 (en) 2009-10-02 2014-10-28 Foamix Ltd. Topical tetracycline compositions
US20110207768A1 (en) * 2010-02-24 2011-08-25 Quadrx Pharmaceuticals Pharmaceutical combination of antibacterial and antifungal cream
BR112012019025A2 (en) * 2010-03-25 2018-03-06 Sol Gel Tech Ltd composition, use of a composition, method for treating a topical condition, and kit
EP2552459B1 (en) * 2010-04-01 2018-07-18 Cytosorbents Corporation Method of treating inflammation
US20110262550A1 (en) * 2010-04-26 2011-10-27 Thomas James Klofta Method for treating a skin ailment
US8978936B2 (en) 2010-07-12 2015-03-17 Foamix Pharmaceuticals Ltd. Apparatus and method for releasing a unit dose of content from a container
WO2014059009A1 (en) 2012-10-09 2014-04-17 The Procter & Gamble Company Method of identifying synergistic cosmetic combinations
CN104704362B (en) 2012-10-09 2018-08-28 宝洁公司 The method of benefit active and the composition comprising it are assessed in identification
US9138393B2 (en) 2013-02-08 2015-09-22 The Procter & Gamble Company Cosmetic compositions containing substituted azole and methods for improving the appearance of aging skin
US9144538B2 (en) 2013-02-08 2015-09-29 The Procter & Gamble Company Cosmetic compositions containing substituted azole and methods for alleviating the signs of photoaged skin
US20150190543A1 (en) * 2014-01-06 2015-07-09 Verdex Technologies Inc. Coform nanofibrous superabsorbent materials
CA2936409C (en) 2014-02-14 2023-03-14 Mission Pharmacal Company Spray delivery device
WO2015123238A1 (en) 2014-02-14 2015-08-20 Mission Pharmacal Company Stabilized, sprayable emulsion containing active agent particles
ES2894679T3 (en) 2014-02-14 2022-02-15 Mission Pharma Co Sprayable composition containing zinc oxide and a fluoro-olefin propellant
US20170239277A1 (en) * 2016-02-23 2017-08-24 Cmpd Licensing, Llc Compositions and methods for treating an infection
CN104523748A (en) * 2015-01-05 2015-04-22 四川悦康源通药业有限公司 Compound iodine disinfectant and preparation method and application thereof
US11278590B2 (en) 2015-08-05 2022-03-22 Cmpd Licensing, Llc Compositions and methods for treating nail infections
US11793783B2 (en) 2015-08-05 2023-10-24 Cmpd Licensing, Llc Compositions and methods for treating an infection
US10898455B2 (en) 2016-01-07 2021-01-26 Cmpd Licensing, Llc Urea cream formulations
US10898491B2 (en) 2015-12-18 2021-01-26 Cmpd Licensing, Llc Compositions and methods for treating an infection
US11690815B2 (en) 2015-08-05 2023-07-04 Cmpd Licensing Llc Hyperkeratotic skin condition treatments and compositions
US11684567B2 (en) 2015-08-05 2023-06-27 Cmpd Licensing, Llc Compositions and methods for treating an infection
MX2020012139A (en) 2016-09-08 2021-01-29 Vyne Pharmaceuticals Inc Compositions and methods for treating rosacea and acne.
CA3103503A1 (en) 2018-07-02 2020-01-09 Ayuvis Research, Inc. Novel immunodulating small molecules
CN109692183A (en) * 2019-03-13 2019-04-30 欧先富 A kind of sterilizing agent for external use and preparation method thereof for eliminating foot smell
US20210100991A1 (en) * 2019-09-17 2021-04-08 Biointraface Inc. Metal oxide and polymer-controlled delivery systems, sunscreens, treatments, and topical coating applicators for antifungal and antimicrobial agents
PL433169A1 (en) 2020-03-06 2021-09-13 Gdański Uniwersytet Medyczny Lipopeptide conjugates and their salts, method for the preparation thereof, pharmaceutical composition containing a lipopeptide conjugate and its salts for the treatment of chronic wounds

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1525120A (en) * 1974-12-19 1978-09-20 Nelson Res & Dev Topical antimicrobial compositions
EP0085843A1 (en) * 1982-01-27 1983-08-17 Bayer Ag Antimycosic agent
US4912124A (en) * 1984-02-23 1990-03-27 Ortho Pharmaceutical Corporation Antifungal dermatological solution
US5262150A (en) * 1990-09-26 1993-11-16 L'oreal Antifungus composition in dry spray form
EP0884043A1 (en) * 1997-05-21 1998-12-16 N.V. Nutricia Powder-based skin spray

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7708731A (en) * 1976-08-13 1978-02-15 Montedison Spa PROCESS FOR THE PREPARATION OF NEW DRIVER COMPOSITIONS FOR AEROSOLS.
US4221778A (en) * 1979-01-08 1980-09-09 Pennwalt Corporation Prolonged release pharmaceutical preparations
US4600575A (en) * 1979-03-08 1986-07-15 American Home Products Corporation Aerosol anesthetic compositions
DE3628531A1 (en) * 1986-08-22 1988-02-25 Merz & Co Gmbh & Co FOAMABLE CREAMS
US4894239A (en) * 1987-06-02 1990-01-16 Takeda Chemical Industries, Ltd. Sustained-release preparation and production thereof
US4996047A (en) * 1988-11-02 1991-02-26 Richardson-Vicks, Inc. Sustained release drug-resin complexes
US5118494A (en) * 1990-03-23 1992-06-02 Minnesota Mining And Manufacturing Company Use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations
US5290539A (en) * 1990-12-21 1994-03-01 Minnesota Mining And Manufacturing Company Device for delivering an aerosol
ES2216800T3 (en) * 1991-12-18 2004-11-01 Minnesota Mining And Manufacturing Company AEROSOL FORMULATIONS IN SUSPENSION.
US5756071A (en) * 1992-06-03 1998-05-26 Arrowdean Limited Method for nasally administering aerosols of therapeutic agents to enhance penetration of the blood brain barrier
US5593661A (en) * 1993-03-29 1997-01-14 Henry; Richard A. Lidocaine aerosol anaesthetic
CA2178473C (en) * 1993-12-20 2004-08-24 Tsi-Zong Tzou Flunisolide aerosol formulations
US5534242A (en) * 1994-05-02 1996-07-09 Henry; Richard A. Lidocaine-vasoconstrictor aerosol preparation
US5589156A (en) * 1994-05-02 1996-12-31 Henry; Richard A. Prilocaine and hydrofluourocarbon aerosol preparations
US5858331A (en) * 1994-05-02 1999-01-12 Henry; Richard A. Prilocaine and hydrofluorocarbon aerosol preparations
CA2280099C (en) * 1997-02-05 2005-12-27 Jago Pharma Ag Medical aerosol formulations
US6114344A (en) * 1998-07-16 2000-09-05 Aryx Therapeutics Long-acting local anesthetics
US20020082317A1 (en) * 1998-09-11 2002-06-27 Sultan Chemists, Inc. Dental adhesive compositions with desensitizing agents
US6235265B1 (en) * 1998-10-28 2001-05-22 Alliedsignal Inc. Evaporative coolant for topical anesthesia comprising hydrofluorocarbons and/or hydrochlorofluorocarbons
US6432415B1 (en) * 1999-12-17 2002-08-13 Axrix Laboratories, Inc. Pharmaceutical gel and aerosol formulations and methods to administer the same to skin and mucosal surfaces
US6620852B2 (en) * 2001-12-17 2003-09-16 Gerald Brogan Topical anesthetic
DE60228615D1 (en) * 2001-12-21 2008-10-09 3M Innovative Properties Co MEDICAL AEROSOL COMPOSITIONS WITH AN EXCIPIENT COMPOUND CONTAINING AN AMID AND / OR ESTER GROUP
US7186416B2 (en) * 2003-05-28 2007-03-06 Stiefel Laboratories, Inc. Foamable pharmaceutical compositions and methods for treating a disorder
US20060188449A1 (en) * 2003-10-03 2006-08-24 Jane Hirsh Topical aerosol foams
WO2007022090A2 (en) * 2005-08-13 2007-02-22 Collegium Pharmaceutical, Inc. Topical delivery with a carrier fluid

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1525120A (en) * 1974-12-19 1978-09-20 Nelson Res & Dev Topical antimicrobial compositions
EP0085843A1 (en) * 1982-01-27 1983-08-17 Bayer Ag Antimycosic agent
US4912124A (en) * 1984-02-23 1990-03-27 Ortho Pharmaceutical Corporation Antifungal dermatological solution
US5262150A (en) * 1990-09-26 1993-11-16 L'oreal Antifungus composition in dry spray form
EP0884043A1 (en) * 1997-05-21 1998-12-16 N.V. Nutricia Powder-based skin spray

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9359471B2 (en) 2014-04-21 2016-06-07 Gaco Western, LLC Foam compositions

Also Published As

Publication number Publication date
WO2005115336A2 (en) 2005-12-08
US20050255048A1 (en) 2005-11-17

Similar Documents

Publication Publication Date Title
WO2005115336A3 (en) Sprayable formulations for the treatment of acute inflammatory skin conditions
WO2005087195A3 (en) Novel compositions for topical delivery
WO2008008397A8 (en) Fatty acid pharmaceutical foam
WO2005000241A8 (en) Compositons and methods for topical administration
WO2006037116A3 (en) Semi-solid delivery vehicle and pharmaceutical compositions
DE60006069D1 (en) TOPICAL SPRAYS CONTAINING A FILM-FORMING COMPOSITION
WO2006129161A3 (en) Vitamin formulation
EP1138314A3 (en) Controlled delivery system of antifungal and keratolytic agents for local treatment of fungal infections of the nail and surrounding tissues
DK1299108T3 (en) Parasitic composition and method of preparing this composition
WO2007070679A3 (en) Compositions and methods for dermally treating pain
CA2567575A1 (en) Organo-gel formulations for therapeutic applications
WO2006056711A3 (en) Oral medicament for the modified release of at least one active principle, in multimicrocapsule form
WO2007066149A3 (en) Topical pharmaceutical compositions
AU4261097A (en) Compositions and methods for topical application of therapeutic agents
WO2008042619A3 (en) Self-preserved aqueous pharmaceutical compositions
WO2005110418A3 (en) Transdermal administration of phycotoxins
WO2007070694A3 (en) Spray-on formulations and methods for dermal delivery of drugs
WO2009093264A3 (en) Pharmaceutical combinations comprising specified age breaker and further drugs, i.a. antihypertensive drugs, antidiabetic drugs etc.
CA2494473A1 (en) Stabilized protein compositions for topical administration and methods of making same
WO2005082416A3 (en) Antimicrobial preservatives to achieve multi-dose formulation using beta-cyclodextrins for liquid dosage forms
WO2007100376A3 (en) Compositions and methods for dermal delivery of drugs
WO2005025486A8 (en) Skincare compositions comprising salicyclic acid
BRPI0515555A (en) pharmaceutical composition comprising temozolomide ester
US11045483B2 (en) Pain-killing composition comprising a salicylic acid derivative
HK1056318A1 (en) Composition for inhalation comprising delta-9-tetrahydrocannabinol in a semiaqueous solvent.

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DPEN Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101)
NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Ref document number: DE

WWE Wipo information: entry into national phase

Ref document number: 7213/DELNP/2006

Country of ref document: IN

122 Ep: pct application non-entry in european phase